- Investors Should Be Eyeing Implant Sciences For The Same Reasons Potential Acquirers Are
- Sentiment Shows Investors Bullish On Aeterna In 2013: Here's Why
- Progress With TSL Makes Implant Sciences An Attractive Investment At Current Prices
- M&A Activity In Medical Devices Could See Focus Shift To MRI Interventions
- Lpathomab Offers Hope In Billion-Dollar Neurotrauma And Pain Markets
LastFinancier
LastFinancier
Stop FollowingLastFinancier
ABOUT
The Last Financier is an independent investor concerned with not only preserving his wealth, but also growing invested capital. He strikes a balance between income-yielding investments, and speculative equities to enhance his portfolio’s alpha. He follows macro trends and delves in misunderstood situations.
SNAPSHOT
- Description: Occasional investor. Trading frequency: Weekly
- Interests: Dividend stock ideas & income, Stocks - long, Stocks - short, Tech stocks
COMPANY
Book
Currently, there are no book details for LastFinancier.
Latest Comments
more »
- The bureaucratic nature of ... on IMSC Value-Driver Imminent As Management Hints ...
- In a perfect market, yes, S... on FDA Gives The 'OK' In Biggest News For This Med...
- According to this video int... on MRI Interventions' ClearPoint: How Intuitive Su...
Latest comments on LastFinancier's Articles
- Fincher on Investors Should Be Eyeing Implant Sciences For...
- skewb on Investors Should Be Eyeing Implant Sciences For...
- Mukticat on Investors Should Be Eyeing Implant Sciences For...
- Fincher on Investors Should Be Eyeing Implant Sciences For...
- Mukticat on Investors Should Be Eyeing Implant Sciences For...
LATEST ARTICLES & INSTAPOSTS
more »


